CSBR vs REGN · P/E 16, rev $56.9M vs P/E 14, rev $14.34B
Champions Oncology Inc (CSBR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CSBR and REGN stock pages for the full models.
Not investment advice.